REG - Mediclinic Intnl plc - Result of AGM <Origin Href="QuoteRef">MDCM.L</Origin>
RNS Number : 0808MMediclinic International plc26 July 2017Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDCJSE Share Code: MEI
NSX Share Code: MEPISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
("Mediclinic", the "Company" or the "Group")
26 July 2017
ANNOUNCEMENT OF THE ANNUAL GENERAL MEETING POLL RESULTS
Mediclinic announces that at its Annual General Meeting ("AGM") held on 25 July 2017, all resolutions set out in the notice of the AGM were passed by the requisite majority of votes by shareholders by way of poll. The results of the poll for each resolution were as follows:
TOTAL SHARES VOTED
% OF ISSUED SHARE CAPITAL VOTED
VOTES FOR
%
VOTES AGAINST
%
VOTES WITHHELD
ORDINARY RESOLUTIONS
1.
To receive the Company's financial statements and the reports by the Directors and auditors
643,346,097
87.26%
642,608,938
99.99%
211
0.01%
736,948
2.
To approve the Directors' Remuneration Report
643,346,097
87.26%
618,212,690
96.25%
24,075,900
3.75%
1,057,507
3.
To approve the amended Directors' Remuneration Policy
643,346,097
87.26%
614,711,926
95.95%
25,915,697
4.05%
2,718,474
4.
To declare a final dividend of 4.70 pence per ordinary share
643,346,097
87.26%
642,966,257
99.99%
211
0.01%
379,629
5.
To elect Jurgens Myburgh as a Director
643,346,097
87.26%
640,899,142
99.68%
2,060,463
0.32%
386,492
6.
To re-elect Danie Meintjes as a Director
643,346,097
87.26%
642,864,882
99.99%
94,723
0.01%
386,492
7.
To re-elect Dr Edwin Hertzog as a Director
643,346,097
87.26%
625,998,995
97.38%
16,833,567
2.62%
513,535
8.
To re-elect Jannie Durand as a Director
643,346,097
87.26%
612,105,167
95.26%
30,444,213
4.74%
796,717
9.
To re-elect Alan Grieve as a Director
643,346,097
87.26%
640,694,983
99.93%
445,220
0.07%
2,205,894
10.
To re-elect Seamus Keating as a Director
643,346,097
87.26%
641,082,006
99.99%
46,572
0.01%
2,217,519
11.
To re-elect Prof Dr Robert Leu as a Director
643,346,097
87.26%
641,083,644
99.99%
44,934
0.01%
2,217,519
12.
To re-elect Nandi Mandela as a Director
643,346,097
87.26%
642,901,226
99.99%
49,254
0.01%
395,617
13.
To re-elect Trevor Petersen as a Director
643,346,097
87.26%
632,937,299
98.72%
8,191,279
1.28%
2,217,519
14.
To re-elect Desmond Smith as a Director
643,346,097
87.26%
639,878,832
99.87%
836,521
0.13%
2,630,744
15.
To re-appoint PricewaterhouseCoopers LLP as auditors of the Company
643,346,097
87.26%
642,446,940
99.99%
3,656
0.01%
895,501
16.
To authorise the Audit and Risk Committee to determine the remuneration of the auditors
643,346,097
87.26%
642,417,589
99.98%
120,859
0.02%
807,649
17.
To authorise the Directors to make political donations
643,346,097
87.26%
566,825,468
89.04%
69,771,641
10.96%
6,748,988
18.
To authorise the Directors to allot ordinary shares
643,346,097
87.26%
527,047,324
82.04%
115,391,424
17.96%
907,349
SPECIAL RESOLUTIONS
19.
To authorise the Directors to dis-apply the statutory pre-emption rights
643,346,097
87.26%
583,771,316
91.13%
56,840,187
8.87%
2,734,594
20.
To authorise the Directors to dis-apply pre-emption rights for purposes of acquisitions or capital investments
643,346,097
87.26%
591,889,385
93.19%
43,253,058
6.81%
8,203,654
21.
To authorise the amendment to the Articles of Association
643,346,097
87.26%
641,126,245
99.99%
1,314
0.01%
2,218,538
22.
To approve the reduction in minimum notice period for general meetings (other than annual general meetings)
643,346,097
87.26%
617,065,427
96.43%
22,854,064
3.57%
3,426,606
VOTES OF SHAREHOLDERS EXCLUDING THE CONTROLLING SHAREHOLDERON ELECTION AND RE-ELECTION OF INDEPENDENT NON-EXECUTIVE DIRECTORS
ORDINARY RESOLUTIONS
TOTAL SHARES VOTED
% OF ISSUED SHARE CAPITAL VOTED
VOTES FOR
%
VOTES AGAINST
%
VOTED WITHHELD
9.
To re-elect Alan Grieve as a Director
571,230,713
77.48%
568,579,599
99.92%
445,220
0.08%
2,205,894
10.
To re-elect Seamus Keating as a Director
571,230,713
77.48%
568,966,622
99.99%
46,572
0.01%
2,217,519
11.
To re-elect Prof Dr Robert Leu as a Director
571,230,713
77.48%
568,968,260
99.99%
44,934
0.01%
2,217,519
12.
To re-elect Nandi Mandela as a Director
571,230,713
77.48%
570,785,842
99.99%
49,254
0.01%
395,617
13.
To re-elect Trevor Petersen as a Director
571,230,713
77.48%
560,821,915
98.56%
8,191,279
1.44%
2,217,519
14.
To re-elect Desmond Smith as a Director
571,230,713
77.48%
567,763,448
99.85%
836,521
0.15%
2,630,744
Notes:
1.
Any proxy appointments giving discretion to the Chairman of the Meeting have been included in the "For" total.
2.
A vote "Withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.
3.
The Company's total ordinary shares in issue (total voting rights) as at 25 July 2017 was 737243 810 ordinary shares of 10 pence each. Ordinary shareholders are entitled to one vote per ordinary share held.
4.
As the Company has a controlling shareholder, Remgro Limited, as defined in the Financial Conduct Authority's Listing Rules, each resolution to elect an independent non-executive director (resolutions 9 to 14) have under Listing Rule 9.2.2E been approved by a majority of the votes cast by:
(a) the shareholders of the Company as a whole; and
(b) the independent shareholders of the Company, that is, all the shareholders entitled to vote on each resolution, excluding the controlling shareholder.
In accordance with paragraph 9.6.2 of the Listing Rules, a copy of the resolutions passed at the meeting has been submitted to the National Storage Mechanism and will shortly be available for inspection at http://www.morningstar.co.uk/uk/NSM.
The complete poll results and details of proxy votes lodged before the AGM will be available shortly on the Company's website at www.mediclinic.com.
About Mediclinic International plc
Mediclinic is an international private healthcare group with operating platforms in Southern Africa (South Africa and Namibia), Switzerland and the United Arab Emirates. Its core purpose is to enhance the quality of life of patients by providing acute care, specialist-orientated, multi-disciplinary healthcare services. Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a LSE listed and UK-based private healthcare group.
Mediclinic comprises 74 hospitals and 37 clinics. Mediclinic Southern Africa operates 49 hospitals and 2 day clinics throughout South Africa and 3 hospitals in Namibia with more than 8 000 inpatient beds in total; Hirslanden operates 16 private acute care facilities and 4 clinics in Switzerland with more than 1 600 inpatient beds; and Mediclinic Middle East operates 6 hospitals and 31 clinics with more than 700 inpatient beds in the United Arab Emirates.
During February 2016, the combination of the Company (previously named Al Noor Hospitals Group plc), with operations mainly in Abu Dhabi in the United Arab Emirates, and Mediclinic International Limited was completed. Mediclinic International Limited was a South African based international private healthcare group founded in 1983 and listed on the JSE, the South African stock exchange, since 1986, with operations in South Africa, Namibia, Switzerland and the United Arab Emirates (mainly in Dubai). The combination resulted in the renaming of the enlarged group to Mediclinic International plc.
Mediclinic has a primary listing on the Main Market of the LSE, with secondary listings on the JSE in South Africa and the NSX in Namibia.
For further information, please contact:
Capita Company Secretarial Services Limited
Victoria Dalby
+44 (0)207 954 9600
Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181
Media queries
FTI Consulting
Brett Pollard/Debbie Scott (UK)
+44 (0)20 3727 1000
Frank Ford (South Africa)
+27 (0)21 487 9000
Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom
Website:www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
This information is provided by RNSThe company news service from the London Stock ExchangeENDRAGSEEFAIFWSEFW
Recent news on Mediclinic International
See all newsREG - Mediclinic Intnl plc - De-listing and cancellation of trading of shares
AnnouncementREG - Public Invest. Corp Mediclinic Intnl plc - Form 8.3 - Mediclinic International PLC
AnnouncementREG - Stock Exch Notice Mediclinic Intnl plc - Cancellation - Mediclinic International plc
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
Announcement